Actuate Therapeutics, Inc. Preferred Stock, Shares Outstanding
Actuate Therapeutics, Inc. (ACTU) had Preferred Stock, Shares Outstanding of 0 shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesOutstanding · last filed 2026-08-14
- 2026-06-30: Preferred Stock, Shares Outstanding 0.00 shares.
- 2026-03-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-12-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-09-30: Preferred Stock, Shares Outstanding 0.00 shares.
| Period end | Preferred Stock, Shares Outstanding |
|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-14 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-14 |
| 2025-12-31 | 0.00 shares 10-Q · filed 2026-08-14 |
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-13 |
| 2025-06-30 | 0.00 shares 10-Q · filed 2025-08-14 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-15 |
| 2024-12-31 | 0.00 shares 10-K · filed 2026-03-26 |
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-13 |
| 2023-12-31 | 0.00 shares 10-K · filed 2025-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B |